Assessment of Adeno-associated Virus Purity by Capillary Electrophoresis-based Western

Overview

Journal Mol Ther Methods Clin Dev

Publisher Cell Press

Date 2024 Sep 16

PMID 39282080

Authors

Julyana Acevedo

Yiling Bi

Jessica Gee

Santoshkumar L Khatwani

Affiliations

Soon will be listed here.

Abstract

A rigorous analytical assessment of recombinant adeno-associated virus (rAAV)-based drug products is critical for their successful development as clinical candidates. It is especially important to ascertain high purity while simultaneously ensuring low levels of impurities in the final drug product. One approach to evaluate the purity of rAAV drug products is to determine the relative stoichiometry of the three viral proteins (VPs) that comprise an rAAV capsid, and the levels of impurities in the final drug product. Here we present two capillary electrophoresis-western (CE-western) assays for quantifying (1) the relative stoichiometry of VP using the anti-AAV B1 antibody, and (2) residual levels of a baculovirus protein impurity, GP64, using the anti-GP64 antibody. In each assay, various purified samples from diverse AAV serotypes were analyzed to determine their VP ratio or GP64 levels. The ratio of VP3/VP1 in rAAV samples was correlated with biological activity, and the clearance of GP64 from the manufacturing process was demonstrated. The results obtained from both assays were further supported by liquid chromatography-mass spectrometry analyses. Overall, we report that CE-western is a high-throughput platform that utilizes low sample volumes for a rapid, sensitive, and robust assessment of the identity, composition, and purity of rAAV drug products.

References

ONeill R, Bhamidipati A, Bi X, Deb-Basu D, Cahill L, Ferrante J . Isoelectric focusing technology quantifies protein signaling in 25 cells. Proc Natl Acad Sci U S A. 2006; 103(44):16153-8. PMC: 1618307. DOI: 10.1073/pnas.0607973103. View

Bosma B, du Plessis F, Ehlert E, Nijmeijer B, de Haan M, Petry H . Optimization of viral protein ratios for production of rAAV serotype 5 in the baculovirus system. Gene Ther. 2018; 25(6):415-424. DOI: 10.1038/s41434-018-0034-7. View

Wang D, Tai P, Gao G . Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov. 2019; 18(5):358-378. PMC: 6927556. DOI: 10.1038/s41573-019-0012-9. View

Onishi T, Nonaka M, Maruno T, Yamaguchi Y, Fukuhara M, Torisu T . Enhancement of recombinant adeno-associated virus activity by improved stoichiometry and homogeneity of capsid protein assembly. Mol Ther Methods Clin Dev. 2023; 31:101142. PMC: 10663676. DOI: 10.1016/j.omtm.2023.101142. View

Oh K . Technical Considerations for Contemporary Western Blot Techniques. Methods Mol Biol. 2021; 2261:457-479. DOI: 10.1007/978-1-0716-1186-9_29. View

Zhang C, Meagher M . Highly Sensitive SDS Capillary Gel Electrophoresis with Sample Stacking Requiring Only Nanograms of Adeno-Associated Virus Capsid Proteins. Methods Mol Biol. 2019; 1972:263-270. DOI: 10.1007/978-1-4939-9213-3_19. View

Santiago-Ortiz J, Schaffer D . Adeno-associated virus (AAV) vectors in cancer gene therapy. J Control Release. 2016; 240:287-301. PMC: 4940329. DOI: 10.1016/j.jconrel.2016.01.001. View

Khatwani S, Pavlova A, Pirot Z . Anion-exchange HPLC assay for separation and quantification of empty and full capsids in multiple adeno-associated virus serotypes. Mol Ther Methods Clin Dev. 2021; 21:548-558. PMC: 8099603. DOI: 10.1016/j.omtm.2021.04.003. View

Roldao A, Vicente T, Peixoto C, Carrondo M, Alves P . Quality control and analytical methods for baculovirus-based products. J Invertebr Pathol. 2011; 107 Suppl:S94-105. DOI: 10.1016/j.jip.2011.05.009. View

10.

Wolfram J, Donahue J . Gene therapy to treat cardiovascular disease. J Am Heart Assoc. 2013; 2(4):e000119. PMC: 3828796. DOI: 10.1161/JAHA.113.000119. View

11.

Gimpel A, Katsikis G, Sha S, Maloney A, Hong M, Nguyen T . Analytical methods for process and product characterization of recombinant adeno-associated virus-based gene therapies. Mol Ther Methods Clin Dev. 2021; 20:740-754. PMC: 7940698. DOI: 10.1016/j.omtm.2021.02.010. View

12.

Wang R, Deng F, Hou D, Zhao Y, Guo L, Wang H . Proteomics of the Autographa californica nucleopolyhedrovirus budded virions. J Virol. 2010; 84(14):7233-42. PMC: 2898249. DOI: 10.1128/JVI.00040-10. View

13.

Zhang X, Jin X, Liu L, Zhang Z, Koza S, Yu Y . Optimized Reversed-Phase Liquid Chromatography/Mass Spectrometry Methods for Intact Protein Analysis and Peptide Mapping of Adeno-Associated Virus Proteins. Hum Gene Ther. 2021; 32(23-24):1501-1511. PMC: 8742267. DOI: 10.1089/hum.2021.046. View

14.

Bracewell D, Smith V, Delahaye M, Smales C . Analytics of host cell proteins (HCPs): lessons from biopharmaceutical mAb analysis for Gene therapy products. Curr Opin Biotechnol. 2021; 71:98-104. DOI: 10.1016/j.copbio.2021.06.026. View

15.

Sormunen A, Koivulehto E, Alitalo K, Saksela K, Laham-Karam N, Yla-Herttuala S . Comparison of Automated and Traditional Western Blotting Methods. Methods Protoc. 2023; 6(2). PMC: 10142486. DOI: 10.3390/mps6020043. View

16.

Oyama H, Ishii K, Maruno T, Torisu T, Uchiyama S . Characterization of Adeno-Associated Virus Capsid Proteins with Two Types of VP3-Related Components by Capillary Gel Electrophoresis and Mass Spectrometry. Hum Gene Ther. 2021; 32(21-22):1403-1416. PMC: 10112878. DOI: 10.1089/hum.2021.009. View

17.

Wu C, Soh K, Wang S . Ion-exchange membrane chromatography method for rapid and efficient purification of recombinant baculovirus and baculovirus gp64 protein. Hum Gene Ther. 2007; 18(7):665-72. DOI: 10.1089/hum.2007.020. View

18.

Sonboli R, Najafi Z, Zarezadeh N, Yazdani M, Behrouz H . Improving SDS-PAGE method for monoclonal antibodies: The advantages of Tris-Acetate over Tris-Glycine SDS-PAGE system and comparison with CE-SDS method. Protein Expr Purif. 2021; 182:105845. DOI: 10.1016/j.pep.2021.105845. View

19.

Lam A, Zhang J, Frabutt D, Mulcrone P, Li L, Zeng L . Fast and high-throughput LC-MS characterization, and peptide mapping of engineered AAV capsids using LC-MS/MS. Mol Ther Methods Clin Dev. 2022; 27:185-194. PMC: 9563341. DOI: 10.1016/j.omtm.2022.09.008. View

20.

Yang T, Braun M, Lembke W, McBlane F, Kamerud J, DeWall S . Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper. Mol Ther Methods Clin Dev. 2022; 26:471-494. PMC: 9418752. DOI: 10.1016/j.omtm.2022.07.018. View